Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ProQR Therapeutics (PRQR) Other Operating Expenses (2021)

Historic Other Operating Expenses for ProQR Therapeutics (PRQR) over the last 2 years, with Q4 2022 value amounting to -$763145.0.

  • ProQR Therapeutics' Other Operating Expenses fell 2085.17% to -$763145.0 in Q4 2022 from the same period last year, while for Sep 2023 it was -$763145.0, marking a year-over-year increase of 6970.32%. This contributed to the annual value of -$3.0 million for FY2024, which is 993.17% down from last year.
  • Per ProQR Therapeutics' latest filing, its Other Operating Expenses stood at -$763145.0 for Q4 2022, which was down 2085.17% from -$617063.9 recorded in Q3 2022.
  • ProQR Therapeutics' Other Operating Expenses' 5-year high stood at -$617063.9 during Q3 2022, with a 5-year trough of -$763145.0 in Q4 2022.